DocDollars

Smith+Nephew, Inc.

MA · United States · Reporting entity ID 100000005456

Total reported 2019–2025
$342.4M
#46 of 2,960 reporting companies — 0.4% of all reported industry payments
$308.1M in general payments across 457,204 records, plus $34.3M in research funding across 5,417 records.

How it breaks down

General payments $308,109,920
Research funding $34,292,576

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Smith+Nephew, Inc. reported $342.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #46 of 2,960 reporting companies. 10% of that was research funding and 90% general payments such as consulting, speaking, food and travel. 457,204 general payment records and 5,417 research records were filed.

Common questions about Smith+Nephew, Inc.

How much has Smith+Nephew, Inc. paid US doctors?

Smith+Nephew, Inc. reported $342,402,497 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $308,109,920 in general payments, $34,292,576 in research funding.

How does Smith+Nephew, Inc. rank among drug and device companies?

It ranks #46 of 2,960 reporting entities by total reported value, about 0.4% of all industry payments in the dataset.

Does a payment from Smith+Nephew, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.